Fingerprint
Dive into the research topics of 'High-dose medroxyprogesterone acetate (MPA) in advanced epithelial ovarian cancer resistant to first- or second-line chemotherapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
High-dose medroxyprogesterone acetate (MPA) in advanced epithelial ovarian cancer resistant to first- or second-line chemotherapy
C. Mangioni, S. Franceschi, C. La Vecchia, M. D'Incalci
Research output: Contribution to journal › Article › peer-review